Video
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how changes to the Food, Drug, and Cosmetic Act help address shortages of critical drugs.
Chris Topoleski, director of federal regulatory affairs for ASHP discusses how changes to the Food, Drug, and Cosmetic Act help address shortages of critical drugs.
This video was taken at ASHP's Summer Meetings and Exposition in June 2015.